E
EOFlow Co Ltd
KOSDAQ:294090
EOFlow Co Ltd
KOSDAQ:294090
Price:
1 490
KRW
Market Closed
Market Cap:
₩62B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EOFlow Co Ltd
Revenue
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
EOFlow Co Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
EOFlow Co Ltd
KOSDAQ:294090
|
Revenue
₩5B
|
CAGR 3-Years
94%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Suheung Co Ltd
KRX:008490
|
Revenue
₩722.3B
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
9%
|
|
|
SD Biosensor Inc
KRX:137310
|
Revenue
₩694.6B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Revenue
₩66.4B
|
CAGR 3-Years
21%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Revenue
₩84.2B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Revenue
₩174.9B
|
CAGR 3-Years
34%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
No Stocks Found
EOFlow Co Ltd
Glance View
EOFlow Co., Ltd. provides drug delivery solutions for patients. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2020-09-14. The firm's main products include wearable insulin pumps, insulin infusion regulators for blood sugar control in diabetic patients.
Intrinsic Value
302.51
KRW
Overvaluation 80%
E
See Also
What is EOFlow Co Ltd's Revenue?
Revenue
5B
KRW
5B
KRW
Based on the financial report for Dec 31, 2024, EOFlow Co Ltd's Revenue amounts to 5B KRW.
What is EOFlow Co Ltd's Revenue growth rate?
Revenue CAGR 3Y
94%
94%
Over the last year, the Revenue growth was -24%. The average annual Revenue growth rates for EOFlow Co Ltd have been 94% over the past three years .
